CA2777686A1 - Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations - Google Patents

Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations Download PDF

Info

Publication number
CA2777686A1
CA2777686A1 CA2777686A CA2777686A CA2777686A1 CA 2777686 A1 CA2777686 A1 CA 2777686A1 CA 2777686 A CA2777686 A CA 2777686A CA 2777686 A CA2777686 A CA 2777686A CA 2777686 A1 CA2777686 A1 CA 2777686A1
Authority
CA
Canada
Prior art keywords
cells
seq
set forth
sequence set
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2777686A
Other languages
English (en)
Inventor
Katherine S. Bowdish
Anke Kretz-Rommel
John Mcwhirter
Toshiaki Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/894,672 external-priority patent/US9249229B2/en
Priority claimed from US10/996,316 external-priority patent/US7408041B2/en
Priority claimed from US11/171,567 external-priority patent/US20060057651A1/en
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of CA2777686A1 publication Critical patent/CA2777686A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2777686A 2004-07-20 2005-07-19 Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations Abandoned CA2777686A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/894,672 2004-07-20
US10/894,672 US9249229B2 (en) 2000-12-08 2004-07-20 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US10/996,316 US7408041B2 (en) 2000-12-08 2004-11-23 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US10/996,316 2004-11-23
US11/171,567 2005-06-30
US11/171,567 US20060057651A1 (en) 2000-12-08 2005-06-30 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
CA2574488A CA2574488C (fr) 2004-07-20 2005-07-19 Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2574488A Division CA2574488C (fr) 2004-07-20 2005-07-19 Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2777686A1 true CA2777686A1 (fr) 2006-02-23

Family

ID=46232355

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2777686A Abandoned CA2777686A1 (fr) 2004-07-20 2005-07-19 Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations

Country Status (1)

Country Link
CA (1) CA2777686A1 (fr)

Similar Documents

Publication Publication Date Title
CA2574488C (fr) Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations
US9150661B2 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US8840885B2 (en) Methods for treating chronic lymphocytic leukemia
US20040198661A1 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
AU2012211347B9 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US9249229B2 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
CA2777686A1 (fr) Polypeptides et anticorps provenant de cellules leucemiques lymphocytiques chroniques et leurs utilisations
CA2787818C (fr) Polypeptides et anticorps derives de cellules de leucemie lymphocytique chronique et utilisations correspondantes
AU2004217434B2 (en) Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20160202

FZDE Discontinued

Effective date: 20160202